| 1 |
IHC Diagnosis Panel |
Tissue Block |
IHC |
| 2 |
BRCA 1 / 2 Mutation |
Blood |
NGS |
| 3 |
Breast Cancer Panel 2 (ER, PR, HER-2, Ki-67) |
Tissue Block |
IHC |
| 4 |
Microsatelity Instability MSI for Colon Cancer |
Tissue Block |
IHC Base |
| 5 |
Liquid Biopsy EGFR Response Test (Sensitivity & Registance Mutation) (T790M, LB58R, Exon 19 Deletion) |
Streck Tube Blood |
DDPCR in Streak Tube |
| 6 |
Liquid Biopsy T790M |
Streck Tube Blood |
NGS, WB in Streak tube |
| 7 |
Oncoce pt Sol 1d Compl heTtSl ve (.4n› s‹›iid-T) |
Tissue Block |
NGs |
| 8 |
HER-2/neu By FISH (Herceptin Responsive Test for Breast Canaer 1 |
Tissue Block |
FISH |
| 9 |
PDL-1 by IHC (For Immunotherapy) |
Tissue Block |
IHC |
| 10 |
ALK BY FISH |
Tissue Block |
FISH |
| 11 |
Germline Mutation Panel (For Breast & Ovarian) |
|
FFPE |
| 12 |
EGFR by PCR, ALK & ROS1 by FISH |
Tissue Block |
DNA PCR + FISH |
| 13 |
Human Papilloma Virus (HPV) |
Cervical Swab |
PCR |
| 14 |
Colo - Comprehensive Panel |
Tissue Block |
NGS |
| 15 |
MGMT Methylation Test |
Tissue Block |
MSPCR |
| 16 |
Colo - Essential ( BRAF+MSI) |
Tissue Block |
NGS |
| 17 |
ROS-1 by FISH |
Tissue Block |
FISH |
| 18 |
Oncocept Solid - (52 Gene) |
Tissue Block |
NGs |
| 19 |
IDH 1& 2 Mutation |
Tissue Block |
NGS |
| 20 |
KRAS, NRAS, BRAF Mutation Analysis, MSI by IHC |
Tissue Block |
Nested PCR & Seauencing |
| 21 |
Glioma Panel ( IHC,MGMT, IDH 1&2, 1p19q Deletion) |
Tissue Block |
PCR, FISH,IHC |
| 22 |
lp19q Deletion |
Tissue Block |
FISH |
| 23 |
K RAS Mutation Analysis |
Tissue Block |
Nested PCR & Sequencing |
| 24 |
EGFR Hot Spot Mutation (Exon-18,19,20,21):(Tissue Block Erlotinib Responsive Test) |
WB EDTA |
Nested PCR & Sequencing |
| 25 |
B RAF Mutation Analysis |
Tissue Block |
Nested PCR & Sequencing |
| 26 |
Breast Cancer Panel 1 (ER, PR, HER-2) |
Tissue Block |
IHC |
| 27 |
N RAS Mutation Analysis |
Tissue Block |
Nested PCR & Sequencing |
| 28 |
UGT1A1 Genotyping Test (irririnotican dose) |
Blood |
DNA PCR + PCR 1 |